Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis

被引:32
|
作者
Lin, C. Y. [1 ]
Pfluger, C. M. [1 ]
Henderson, R. D. [1 ]
McCombe, P. A. [1 ]
机构
[1] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4072, Australia
基金
英国医学研究理事会;
关键词
Amyotrophic lateral sclerosis; Apoptosis; Cytokines; Interleukin; 33; Soluble ST2; Neuroinflammation; CENTRAL-NERVOUS-SYSTEM; IL-33; RECEPTOR; DISEASE; CELLS; INITIATION; SECRETION; INSIGHTS; BIOLOGY; IMMUNE;
D O I
10.1016/j.jneuroim.2012.05.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 33 (IL-33) is a cytokine that functions as an alarmin and is released from damaged tissue. The receptor for IL-33 is ST2, which exists as membrane bound and soluble forms. Levels of IL-33 and soluble ST2 (sST2) are elevated in some inflammatory diseases. Amyotrophic lateral sclerosis (ALS) is a disease that is due to loss of motor neurones, with some neuro-inflammation at the site of pathology. This study was performed to measure levels of IL-33 and sST2 in ALS. Serum was obtained from subjects with ALS (n=42) and healthy controls (n=38). Levels of IL-33 and s ST2 were measured with ELISA. The level of II-33 was significantly lower in ALS subjects than healthy controls, and the levels of sST2 were significantly higher. The lower levels of IL-33 could be due to degradation of IL-33 by caspases released from apoptotic cells. However the levels of IL-33 could also be lower due to effects of sST2 which acts as a receptor for IL-33. The levels of sST2 could reflect inflammation in ALS. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:93 / 95
页数:3
相关论文
共 50 条
  • [21] Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis
    T. Matsuishi
    S. Nagamitsu
    H. Shoji
    M. Itoh
    S. Takashima
    T. Iwaki
    N. Shida
    Y. Yamashita
    T. Sakai
    H. Kato
    Journal of Neural Transmission, 1999, 106 : 943 - 948
  • [22] Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis
    Matsuishi, T
    Nagamitsu, S
    Shoji, H
    Itoh, M
    Takashima, S
    Iwaki, T
    Shida, N
    Yamashita, Y
    Sakai, T
    Kato, H
    JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (9-10) : 943 - 948
  • [23] Interleukin-33 and ST2 Signaling in Tumor Microenvironment
    Hong, Jaewoo
    Kim, Soohyun
    Lin, P. Charles
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (01) : 61 - 71
  • [24] Circulating levels of tumour necrosis factor-α and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis
    Poloni, M
    Facchetti, D
    Mai, R
    Micheli, A
    Agnoletti, L
    Francolini, G
    Mora, G
    Camana, C
    Mazzini, L
    Bachetti, T
    NEUROSCIENCE LETTERS, 2000, 287 (03) : 211 - 214
  • [25] Toenail mercury Levels are associated with amyotrophic lateral sclerosis risk
    Andrew, Angeline S.
    Chen, Celia Y.
    Caller, Tracie A.
    Tandan, Rup
    Henegan, Patricia L.
    Jackson, Brian P.
    Hall, Brenda P.
    Bradley, Walter G.
    Stommel, Elijah W.
    MUSCLE & NERVE, 2018, 58 (01) : 36 - 41
  • [26] Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis
    Italiani, Paola
    Carlesi, Cecilia
    Giungato, Paola
    Puxeddu, Ilaria
    Borroni, Barbara
    Bossu, Paola
    Migliorini, Paola
    Siciliano, Gabriele
    Boraschi, Diana
    JOURNAL OF NEUROINFLAMMATION, 2014, 11
  • [27] Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis
    Ilzecka, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2009, 120 (02): : 119 - 122
  • [28] Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma
    Markus Brunner
    Claus Krenn
    Georg Roth
    Bernhard Moser
    Martin Dworschak
    Erika Jensen-Jarolim
    Andreas Spittler
    Thomas Sautner
    Nico Bonaros
    Ernst Wolner
    George Boltz-Nitulescu
    Hendrik Jan Ankersmit
    Intensive Care Medicine, 2004, 30 : 1468 - 1473
  • [29] Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus
    Mok, Mo Yin
    Huang, Fang Ping
    Ip, Wai Ki
    Lo, Yi
    Wong, Fung Yi
    Chan, Eric Yuk Tat
    Lam, Kwok Fai
    Xu, Damo
    RHEUMATOLOGY, 2010, 49 (03) : 520 - 527
  • [30] Lipocalin-2 is increased in amyotrophic lateral sclerosis
    Petrozziello, Tiziana
    Mills, Alexandra N.
    Farhan, Sali M. K.
    Mueller, Kaly A.
    Granucci, Eric J.
    Glajch, Kelly E.
    Chan, James
    Chew, Sheena
    Berry, James D.
    Sadri-Vakili, Ghazaleh
    MUSCLE & NERVE, 2020, 62 (02) : 272 - 283